Author

L. Sanchez-Felipe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J. Neyts· 3 shared K. Dallmeier· 3 shared B. Weynand· 2 shared H. J. Thibaut· 2 shared P. Maes· 2 shared R. Abdelnabi· 2 shared T. Vercruysse· 2 shared V. Lemmens· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

J. Neyts

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge

V. Lemmens, L. Kelchtermans, S. Debaveye, W. Chiu, T. Vercruysse, J. Ma, H. J. Thibaut, J. Neyts, L. Sanchez-Felipe, K. Dallmeier

This study develops a dual-target vaccine against Ebola and yellow fever viruses, showing it protects mice against both pathogens with a single dose.

bioRxiv · Jan 13, 2023 · PreprintImmunology

Updated vaccine protects from infection with SARS-CoV-2 variants, prevents transmission and is immunogenic against Omicron in hamsters

S. Sharma, T. Vercruysse, L. Sanchez-Felipe, W. Kerstens, P. Maes, R. Abdelnabi, C. S. Foo, V. Lemmens, D. Van Looveren, G. Baele, B. Weynand, P. Lemey, J. Neyts, H. J. Thibaut, K. Dallmeier

This study shows an updated vaccine candidate provides full protection against multiple SARS-CoV-2 variants, prevents transmission, and induces neutralizing antibodies against Omicron in hamsters.

bioRxiv · Nov 12, 2021 · PreprintMicrobiology

Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters

R. Abdelnabi, R. Boudewijns, C. S.-Y. Foo, L. Seldeslachts, L. Sanchez-Felipe, X. Zhang, L. Delang, P. Maes, S. J. F. Kaptein, B. Weynand, G. Vande Velde, J. Neyts, K. Dallmeier

This study compares the infectivity and pathogenicity of SARS-CoV-2 variants B.1.1.7 and B.1.351 to early 2020 strains in Syrian hamsters, finding similar disease outcomes but stronger proinflammatory cytokine elevation in B.1.1.7 infections.

bioRxiv · Feb 26, 2021Microbiology